IJR News — today's news from every side
block
verse
w
o
rdys
billionaire
.ai
your
list
Whiteboard
App
quizie
un
school
New Journal
Loading
Genius — OpenServe
News
Home
Popular
Elections
Genius — OpenServe
Trending
Giants GM who engineered Eli Manning trade Ernie Accorsi dies at 84
x/ernie-accorsi
— Sep 20, 2026
Ernie Accorsi, the Giants GM who engineered the Eli Manning trade and hired Tom Coughlin, died at 84; the team said he passed peacefully Saturday with family.
+9
0
Share
Eli Lilly Breaks Ground on $6.5B Houston Facility
x/eli-lilly-and-company
— Sep 21, 2026
Eli Lilly broke ground Sept. 21, 2026 on a $6.5B Houston API plant to make Foundayo, its oral GLP-1 pill, with 600+ jobs as part of a $50B U.S. manufacturing push.
+7
+2
3
Share
Maya Lindstrom
Hope this oral GLP-1 pill becomes more affordable once production ramps up locally.
InnoCare and Lilly Sign Drug Discovery Deal With Up to $3.25 Billion in Milestones
x/eli-lilly-and-company
— Sep 24, 2026
InnoCare shares fell after announcing a pact with Eli Lilly worth up to $3.25 billion in milestones covering as many as five drug targets.
+6
+3
2
Share
Tom Gallagher
Lilly is betting big on InnoCare's platform with those billions in milestones, but execution will decide if it pays off.
CNN’s Elie Honig Says Suggestion Of Pushing Trump’s Sentence To After He’s President Is ‘Preposterous’
x/donald-john-trump
— Nov 19, 2024
CNN senior legal analyst Elie Honig said Tuesday that Manhattan District Attorney Alvin Bragg’s suggestion to postpone President-elect Donald Trump’s sentencing until after his presidential term is “preposterous.” Bragg…
0
Share
IJR
‘Think Of My Dad’: Abdul El-Sayed Defends Campaigning With Obama After Criticizing Him During Presidency
Jillian Butler · 3 min · 11h
‘Very Unusual’: CNN’s Elie Honig Explains What Will Likely Happen With Trump’s Upcoming Sentencing
x/donald-john-trump
— Jan 6, 2025
CNN senior legal analyst Elie Honig said President-elect Donald Trump’s attempt to cancel his upcoming sentencing in relation to Manhattan District Attorney Alvin Bragg’s case against him will lead to a legal…
0
Share
AP Top 25 College Football Teams
Ranking
College football fans argue endlessly over which programs deserve the top spots in the AP Poll based on wins, schedule strength, and legacy.
Share
CNN’s Elie Honig Says SCOTUS Delivered ‘Win For The Parents’ Challenging LGBTQ Curriculum
x/supreme-court-of-the-united-states
— Jun 27, 2025
CNN senior legal analyst Elie Honig said on Friday that the Supreme Court siding with parents who want to opt their children out of mandated LGBTQ storybook lessons was a victory for the First Amendment. The court ruled…
0
Share
Amish Men ‘Shunned’ After Emergency Alert System Went Off
Reporting
— Oct 6, 2023
Several Amish men were reportedly “shunned” after an emergency alert test from the Federal Emergency Management Agency (FEMA) went off on Oct. 4. Former Amish member and TikToker, Eli Yoder shared in a video that three…
0
Share
NY Business Owner Shares What He Believes Is ‘A Blueprint for Indefinite Government Restrictions’ Amid Pandemic
Reporting
— Jul 30, 2021
New York City art gallery owner Eli Klein is expressing his opposition to indoor mask mandates, saying “there has to be an end game.” CNN’s John Berman pointed out on Friday that Klein really does not want to go back to…
0
Share
UK Approves Foundayo Oral GLP-1 Pill; NHS Decision Pending
x/the-united-kingdom
— Aug 10, 2026
The UK has become the first European nation to approve Eli Lilly’s Orforglipron, sold as Foundayo, a once-daily GLP-1 pill for weight management and type 2 diabetes with specific BMI criteria and a multi-dose ramp-up. The MHRA emphasized prescription-only status and ongoing safety reviews, with NHS access still under consideration by NICE and not yet widely available.
+61
0
Share
FaithTap
St. Teresa of Ávila Reforms the Carmelite Order
Teresa founds the Discalced Carmelites at Ávila.
33m · 1 reads
Share
Lilly Plans $2.88B Merida Autoimmune Acquisition
Business
— Sep 3, 2026
Eli Lilly is rapidly expanding beyond its obesity-and-diabetes blockbuster lineup, striking two multi-deal paths: a $2.875 billion-plus acquisition of Merida Biosciences to broaden its autoimmune and antibody-directed therapies, and a $3.83 billion spree to acquire three biotech firms—Curevo, LimmaTech Biologics, and Vaccine Company—to build a broader vaccine and infectious-disease pipeline. The moves underscore a strategy to diversify growth into immunology, infectious diseases, and autoantibody therapies while managing revenue risk from reliance on a small number of weight‑loss drugs.
+2
0
Share
